You are here

  • Home
  • Archive
  • Volume 13, Issue 8
  • Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands

Article info

Article menu

This article has a correction. Please see:

Cardiovascular medicine
Original research
Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands

Authors

  • Xuechun Li PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Maarten J Bijlsma PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The NetherlandsLaboratory of Population Health, Max-Planck-Institute for Demographic Research, Rostock, Germany PubMed articlesGoogle scholar articles
  • Jens H J Bos PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Catharina C M Schuiling-Veninga PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  • Eelko Hak PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Xuechun Li; xuechen.li{at}rug.nl
View Full Text

Citation

Li X, Bijlsma MJ, Bos JHJ, et al
Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands
BMJ Open 2023;13:e068721. doi: 10.1136/bmjopen-2022-068721

Publication history

  • Received September 29, 2022
  • Accepted July 27, 2023
  • First published August 9, 2023.
Online issue publication 
August 09, 2023
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.